Compare JNJ & MA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JNJ | MA |
|---|---|---|
| Founded | 1886 | 1966 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 589.2B | 482.1B |
| IPO Year | 2003 | 2005 |
| Metric | JNJ | MA |
|---|---|---|
| Price | $248.37 | $517.54 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 24 |
| Target Price | $227.29 | ★ $660.33 |
| AVG Volume (30 Days) | ★ 7.8M | 3.6M |
| Earning Date | 04-21-2026 | 04-30-2026 |
| Dividend Yield | ★ 2.14% | 0.68% |
| EPS Growth | ★ 90.50 | 18.93 |
| EPS | 11.03 | ★ 16.52 |
| Revenue | N/A | ★ $32,791,000,000.00 |
| Revenue This Year | $6.63 | $16.18 |
| Revenue Next Year | $7.21 | $12.30 |
| P/E Ratio | ★ $22.07 | $31.14 |
| Revenue Growth | N/A | ★ 16.42 |
| 52 Week Low | $141.50 | $465.59 |
| 52 Week High | $247.25 | $601.77 |
| Indicator | JNJ | MA |
|---|---|---|
| Relative Strength Index (RSI) | 71.52 | 43.90 |
| Support Level | $201.37 | N/A |
| Resistance Level | N/A | $575.11 |
| Average True Range (ATR) | 3.66 | 12.49 |
| MACD | -0.59 | -1.03 |
| Stochastic Oscillator | 92.80 | 46.26 |
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
Mastercard is the second-largest payment processor in the world, having processed close to $10 trillion in volume during 2024. Mastercard operates in over 200 countries and processes transactions in over 150 currencies.